Oscar Health OSCR
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
Oscar Health (OSCR) Core Market Data and Business Metrics
Latest Closing Price
$13.37Price-Earnings Ratio
133.70Total Outstanding Shares
215.05 Million SharesDividend
No dividendSIC Description
Hospital & Medical Service PlansPrimary Exchange
New York Stock ExchangeHeadquarters
75 Varick Street, New York, NY, 10013
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 5,930,991 Shares | 3.56 | 3/14/2025 | 21,132,664 Shares |
| 6,474,961 Shares | 3.45 | 2/28/2025 | 22,306,293 Shares |
| 5,964,779 Shares | 3.71 | 2/14/2025 | 22,107,216 Shares |
| 2,812,128 Shares | 6.84 | 1/31/2025 | 19,233,332 Shares |
| 3,273,187 Shares | 6.03 | 1/15/2025 | 19,748,016 Shares |
| 3,575,710 Shares | 5.33 | 12/31/2024 | 19,071,330 Shares |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Investing Activities | $-1.39 Billion |
| Net Cash Flow From Financing Activities | $68.39 Million |
| Net Cash Flow From Operating Activities | $978.19 Million |
| Net Cash Flow From Operating Activities, Continuing | $978.19 Million |
| Net Cash Flow From Financing Activities, Continuing | $68.39 Million |
| Net Cash Flow From Investing Activities, Continuing | $-1.39 Billion |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Income/Loss From Continuing Operations After Tax | $26.12 Million |
| Net Income/Loss Attributable To Noncontrolling Interest | $689,000 |
| Basic Earnings Per Share | $0.11 |
| Income Tax Expense/Benefit | $7.30 Million |
| Revenues | $9.18 Billion |
| Benefits Costs and Expenses | $9.12 Billion |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $689,000 |
| Other Comprehensive Income/Loss | $-3.14 Million |
| Comprehensive Income/Loss Attributable To Parent | $22.30 Million |
| Comprehensive Income/Loss | $22.98 Million |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Equity Attributable To Noncontrolling Interest | $2.84 Million |
| Current Assets | $2.85 Billion |
| Noncurrent Assets | $2.00 Billion |
| Liabilities | $3.82 Billion |
| Noncurrent Liabilities | $360.84 Million |
| Fixed Assets | $66.79 Million |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||